about
Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levelsExome sequencing reveals VCP mutations as a cause of familial ALSA two-stage genome-wide association study of sporadic amyotrophic lateral sclerosisSelenium neurotoxicity in humans: bridging laboratory and epidemiologic studiesFUS mutations in sporadic amyotrophic lateral sclerosisExposure to pesticides and risk of amyotrophic lateral sclerosis: a population-based case-control study.Endozepines in recurrent stupor.CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients.Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72.Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study.C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population.ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion.Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite.Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutationHFE p.H63D polymorphism does not influence ALS phenotype and survival.Genetic counselling in ALS: facts, uncertainties and clinical suggestions.Extrapyramidal and cognitive signs in amyotrophic lateral sclerosis: A population based cross-sectional study.Amyotrophic lateral sclerosis: prognostic indicators of survival.Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study.Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence?Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment.Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study.Ultrasound assessment of diaphragmatic function in patients with amyotrophic lateral sclerosis.Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy.A novel SOD1 mutation in a young amyotrophic lateral sclerosis patient with a very slowly progressive clinical course.Neurogenic T wave inversion in pure left insular stroke associated with hyperhomocysteinaemia.Noninvasive and invasive ventilation and enteral nutrition for ALS in Italy.Comment on 'Huntington's disease presenting as ALS'.Replication of association of CHRNA4 rare variants with sporadic amyotrophic lateral sclerosis: the Italian multicentre study.Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset.Changes in routine laboratory tests and survival in amyotrophic lateral sclerosis.Rapidly progressive amyotrophic lateral sclerosis in a young patient with hereditary neuropathy with liability to pressure palsies.Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort.Riluzole and other prognostic factors in ALS: a population-based registry study in Italy.Bilateral posterior medullary and cervical stroke: a case report.Do flavan-3-ols from green tea reach the human brain?Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study.A further Rasch study confirms that ALSFRS-R does not conform to fundamental measurement requirements.Teaching NeuroImage: When right atrial myxoma meets patent foramen ovale: a case of paradoxical brain embolism.TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations.
P50
Q24336201-1A74D3B6-E7BF-4DCD-863F-A8A7E130A376Q24631513-365F0847-472B-4375-803C-387B51E69E49Q24648667-A324EB37-3C11-4612-8173-723BB17F6AE1Q27012686-DC9C8B13-A82D-4D83-9A8D-D121551F1E87Q33937517-FC07828D-135D-4DD7-B8E8-62C5F4CB2718Q34023998-B805F518-40D8-4EED-8979-616B6C5817BEQ34460780-3286D4C2-544E-453B-A07B-FFF80592CD8BQ35236293-36540634-D642-43ED-9CEB-B0D4339718DFQ35776923-ABC10611-4404-4327-A504-867DC5CDE136Q35891811-54A172BD-BCD6-4311-9612-64397276036EQ36024669-44CB2971-1E61-405C-9247-139DBF4CB19EQ36642638-45F7ED2C-7358-4343-8C47-396E6A7B388BQ37164902-BE13BEE4-F32B-421B-B126-FBDCC637EA99Q37408567-289490A9-7413-45AD-8A3A-0D68A9087166Q37531688-B42172D8-7EE6-4B83-BDB2-AE15DFE613B8Q38119935-31AE7169-092F-451E-9496-E4A5ADD06578Q39371574-7E422F91-3E75-4A09-B029-F8F55FFE51DBQ40266440-AB345DF2-9A23-48A4-B0F8-72614B4EE979Q40385575-8F028645-8612-431A-A02F-756FB88B1877Q40443836-36E2274F-73C3-4F10-A168-27BAF2669479Q40726584-5F0E005F-C877-46B3-A595-2ADAD850D6BCQ40729676-63D7A0AA-9EF4-4E1A-987F-780D5B2AFDA7Q40749038-58D5D0B8-B81D-4956-944B-3027EDD99760Q41553914-AB5CC160-2072-476B-9D14-8E81BF0087C6Q42925366-C814ACA8-1534-40B0-A9CF-5C815D7B2C62Q43068828-ECCDAF4B-94AA-4BC2-929F-45CEF31E1D8DQ43860201-F4C3A4A4-E31F-49AA-8C60-CE2ABB3B0D07Q45296102-F9AD6051-C77B-494C-B5E6-E66AB8565A59Q46254712-6D52710A-96CB-43B3-AFFA-F53B443C6F8CQ46454338-0AF22A43-7BAB-4B61-9254-A88F0A802207Q47661191-8742A012-2C76-4A1C-8A0C-B86FFC86BD61Q47815487-59790B83-5378-48B2-BF79-1A2DC7CC7E7AQ47979733-DFB3120C-B476-435A-9980-5818F0010E92Q48101521-FFB05880-AE46-4CCB-9FA5-1D8407354737Q48414004-68E82C79-9DD5-4D18-9E57-226EECC9D568Q48446672-F87E9635-03FD-4CF2-9CFF-357056D64D69Q51166739-0011FE59-FC5F-4EF1-A873-D1F24535BD47Q51636543-D018ED71-99ED-490A-BF84-B60F325940C2Q53443462-755C44CB-181E-4F82-81E9-B83457369DA7Q55059055-922AC1BC-52F9-40E8-A9E0-F266BD8D2E31
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jessica Mandrioli
@ast
Jessica Mandrioli
@en
Jessica Mandrioli
@es
Jessica Mandrioli
@nl
type
label
Jessica Mandrioli
@ast
Jessica Mandrioli
@en
Jessica Mandrioli
@es
Jessica Mandrioli
@nl
prefLabel
Jessica Mandrioli
@ast
Jessica Mandrioli
@en
Jessica Mandrioli
@es
Jessica Mandrioli
@nl
P106
P21
P31
P496
0000-0002-9244-9782